Single embryo transfer (SET) is just one of the effective treatment options available at RMANJ and just one of the ways we’re redefining the IVF experience and expectations of success.

Through a safe, unique, quick, and well-validated embryo selection method called SelectCCS, we’re able to maintain high pregnancy and delivery rates with SET. We’re here to help you have the family you want and just one baby at a time if you choose.

Until recently, visual-based embryo selection methods have limited the use of single embryo transfer, as success rates were not as high as when two or more embryos were transferred. The transfer of two or more embryos may result in high-risk and complicated pregnancies and deliveries. But now, the promise of single embryo transfer – uncompromised success with fewer complications – is  a reality at RMANJ.

The data below comes from RMANJ’s BEST Trial presented recently at the 2012 American Society of Reproductive Medicine Meeting in October. The data shows no difference in pregnancy rates when a single screened embryo is transferred compared to two unscreened embryos. Learn more about this breakthrough study.

Through SET and CCS:

  • Women can avoid health risks that are associated with carrying multiples, including increased chance of Caesarean section, longer recovery periods following birth, and other complications.
  • We also can prevent the numerous medical complications that can affect twins, triplets or higher multiples during pregnancy, birth or for a lifetime, such as premature birth, low birth rate, and respiratory issues.

Ask your RMANJ doctor or nurse about SET and CCS.

In 2013 RMANJ donated SelectCCS to the Foundation for the Assessment and Enhancement of Embryonic Competence (FAEEC), a non-profit organization dedicated to improving outcomes and advancing knowledge in the areas of research, diagnosis, and education. SelectCCS is owned and operated by the Foundation for the Assessment and Enhancement of Embryonic Competence (www.faeec.org).